TY  - JOUR
AU  - Hurtado Morillas, Clara
AU  - Martínez Rodrigo, Abel
AU  - Orden Gutiérrez, José Antonio
AU  - De Urbina Fuentes, Laura
AU  - Mas Zubiri, Alicia
AU  - Domínguez Bernal, Gustavo Ramón
PY  - 2024
DO  - 10.3390/ ani14040605
SN  - 2076-2615
UR  - https://hdl.handle.net/20.500.14352/103346
T2  - Animals
AB  - Canine leishmaniosis (CanL) is a growing health problem for which vaccination is a crucial tool for the control of disease. The successful development of an effective vaccine against this disease relies on eliciting a robust and enduring T-cell immune...
AB  - Simple Summary: Canine leishmaniosis is a potentially fatal disease in dogs caused by the Leishmania parasite. Vaccination seems to be the safest, most cost-effective, and long-lasting control strategy. Currently, there is still no vaccine that...
LA  - eng
PB  - MDPI
KW  - Canine leishmaniosis
KW  - PLGA nanoparticles
KW  - Multi-epitope peptide
KW  - Nanovaccine
KW  - LetiFend®
KW  - Leishmania infantum
TI  - Enhancing Control of Leishmania infantum Infection: A Multi-Epitope Nanovaccine for Durable T-Cell Immunity
TY  - journal article
VL  - 14
ER  -